← Back to Information Portal

Compounded Semaglutide Information

What is Semaglutide?

Semaglutide is a selective glucagon-like peptide-1 (GLP-1) receptor agonist that acts in the areas of the brain involved in regulation of appetite and caloric intake and slows gastric emptying. Our Compounded Semaglutide contains the same active ingredient as Ozempic® and Wegovy®, following a unique dosing protocol for optimal results based on individual goals.

Getting Started

  1. Free Evaluation: Submit your information to speak with your dedicated Patient Care Coordinator
  2. Free Consultation: Meet with one of our medical Providers online or in the office
  3. Home Delivery: Receive your personalized program discreetly at home

Frequently Asked Questions

How much weight can I expect to lose?

Patients report losing 0.5-2 pounds per week or more. Results vary based on dosage, starting weight, activity levels and other factors.

What is the dosing schedule?

Every patient starts at 0.25mg of Compounded Semaglutide per week for the first 4 weeks. Dosage may be adjusted based on weight loss goals, side effects, and appetite suppression achievement.

What are the most common adverse effects?

Potential side effects include abdominal discomfort, constipation, diarrhea, nausea, vomiting, fatigue, and headache. These symptoms may improve over time. Maintaining proper hydration and eating before injection can help minimize side effects.

Do you accept insurance?

Insurance typically does not cover Compounded Semaglutide treatment. However, we do accept HSA and FSA cards for treatment programs.

How much does Semaglutide cost?

Compounded Semaglutide programs are under $299 per month.

What conditions disqualify me for Semaglutide?

Disqualifying conditions include:

  • BMI under 25
  • GFR under 59
  • Diabetes
  • Kidney Disease
  • Gallbladder Disease
  • Pancreatitis
  • Medullary Thyroid Carcinoma
  • Multiple Endocrine Neoplasia Syndrome Type 2
  • Unevaluated Thyroid Nodule
  • Pregnancy or Breastfeeding

Disclaimer: We have no affiliation with the manufacturers of Ozempic® or Wegovy®. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S.